User profiles for Laurent P. Rivory

Laurent Rivory

Verified email at unsw.edu.au
Cited by 5971

Clinical pharmacokinetics of docetaxel

SJ Clarke, LP Rivory - Clinical pharmacokinetics, 1999 - Springer
Docetaxel (Taxotere®), a semi-synthetic analog of paclitaxel (Taxol®), is a promoter of
microtubule polymerization leading to cell cycle arrest at G2/M, apoptosis and cytotoxicity. …

Conversion of irinotecan (CPT-11) to its active metabolite, 7-ethyl-10-hydroxycamptothecin (SN-38), by human liver carboxylesterase

LP Rivory, MR Bowles, J Robert, SM Pond - Biochemical pharmacology, 1996 - Elsevier
We have investigated the conversion of the novel anti-topoisomerase I agent CPT-11 (irinotecan;
7-ethyl-10[4-(1-piperidino)-1piperidino]carbonyloxycamptothecin) to its active …

Inflammatory response: an unrecognised source of variability in the pharmacokinetics and pharmacodynamics of cancer chemotherapy

KA Slaviero, SJ Clarke, LP Rivory - The lancet oncology, 2003 - thelancet.com
An important limitation in the use of chemotherapy in cancer treatment is that cytotoxic
agents have small margins of safety compared with other drugs. The largely unpredictable …

The hepatic sinusoid in aging and cirrhosis: effects on hepatic substrate disposition and drug clearance

DG Le Couteur, R Fraser, S Kilmer, LP Rivory… - Clinical …, 2005 - Springer
The fenestrated sinusoidal endothelium (‘liver sieve’) and space of Disse in the healthy liver
do not impede the transfer of most substrates, including drugs and oxygen, from the …

Pharmacokinetic interrelationships of irinotecan (CPT-11) and its three major plasma metabolites in patients enrolled in phase I/II trials.

LP Rivory, MC Haaz, P Canal, F Lokiec… - Clinical cancer research …, 1997 - AACR
Irinotecan (CPT-11) is an analogue of 20(S)-camptothecin with promising activity against
several tumor types. In patients, CPT-11 is metabolized to 7-ethyl-10-hydroxycamptothecin (SN-…

Baseline nutritional assessment in advanced cancer patients receiving palliative chemotherapy

KA Slaviero, JA Read, SJ Clarke, LP Rivory - Nutrition and cancer, 2003 - Taylor & Francis
Depletion of nutritional reserves and significant weight loss can lead to an increased risk of
morbidity, reduced chemotherapy response, and shorter survival in patients with cancer. …

Thymidylate synthase and methylenetetrahydrofolate reductase gene polymorphisms and toxicity to capecitabine in advanced colorectal cancer patients

R Sharma, JM Hoskins, LP Rivory, M Zucknick… - Clinical cancer …, 2008 - AACR
Purpose: To evaluate the effect of thymidylate synthase (TYMS) and methylenetetrahydrofolate
reductase (MTHFR) genotypes on toxicity in patients treated with capecitabine for …

Factors affecting cytochrome P-450 3A activity in cancer patients

SD Baker, RHN Van Schaik, LP Rivory, AJ Ten Tije… - Clinical cancer …, 2004 - AACR
Purpose: The purpose is to identify the demographic, physiologic, and inheritable factors that
influence CYP3A activity in cancer patients Experimental Design: A total of 134 patients (62 …

Identification of a new metabolite of CPT-11 (irinotecan): pharmacological properties and activation to SN-38

…, MC Haaz, JF Riou, J Robert, LP Rivory - Journal of Pharmacology …, 1998 - ASPET
Irinotecan, or CPT-11 (7-ethyl-10-[4-(1-piperidino)-1-piperidino]carbonyloxycamptothecine),
is a water-soluble derivative of camptothecine with promising activity against several types …

Molecular, cellular, and clinical aspects of the pharmacology of 20 (S) camptothecin and its derivatives

LP Rivory, J Robert - Pharmacology & therapeutics, 1995 - Elsevier
The discovery of the plant alkaloid 20(S)camptothecin (CPT), which displayed potent
antitumor activity in preclinical trials, has led to the identification of a novel target of cancer …